Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,46 USD | +1,49% | +10,30% | -56,49% |
06/03 | AGILON HEALTH, INC. : Barclays zet verkoopadvies | ZM |
05/03 | Transcript : Agilon health, inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 12:50 PM |
Omzet 2024 * | 6,39 mld. 6 mld. | Omzet 2025 * | 7,98 mld. 7,49 mld. | Marktkapitalisatie | 2,21 mld. 2,08 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -146 mln. -137 mln. | Nettowinst (verlies) 2025 * | -80 mln. -75,09 mln. | EV/omzet 2024 * | 0,32 x |
Nettoliquiditeiten 2024 * | 176 mln. 165 mln. | Nettoliquiditeiten 2025 * | 164 mln. 154 mln. | EV/omzet 2025 * | 0,26 x |
K/w-verhouding 2024 * |
-15,1
x | K/w-verhouding 2025 * |
-27,9
x | Werknemers | 1.117 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 74,22% |
Recentste transcriptie over agilon health, inc.
1 dag | +1,49% | ||
1 week | +10,30% | ||
Lopende maand | -10,49% | ||
3 maanden | -14,29% | ||
6 maanden | -71,99% | ||
Lopend jaar | -56,49% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Veeral Desai
FOU | Founder | 43 | 01-01-16 |
Steven Sell
CEO | Chief Executive Officer | 57 | 01-06-20 |
Timothy Bensley
DFI | Director of Finance/CFO | 64 | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Sell
CEO | Chief Executive Officer | 57 | 01-06-20 |
Ronald Williams
FOU | Founder | 74 | 01-01-16 |
Sharad Mansukani
BRD | Director/Board Member | 54 | 01-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.94% | 8 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 5,46 | +1,49% | 6 689 365 |
18-04-24 | 5,38 | +7,39% | 5 733 107 |
17-04-24 | 5,01 | +11,83% | 6 790 076 |
16-04-24 | 4,48 | +0,45% | 5 839 816 |
15-04-24 | 4,46 | -9,90% | 5 917 672 |
uitgestelde koers Nyse, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-56,49% | 2,2 mld. | |
-23,40% | 2,93 mld. | |
-30,54% | 2,41 mld. | |
-9,98% | 200 mln. | |
-49,27% | 176 mln. | |
-29,61% | 124 mln. |